Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.

Japan Pharma & Healthcare Company News (Page 5)

Earnings, deals and disclosures from Japan's listed pharma & healthcare companies, in English.

  1. Modalis lines up a ¥1.33 billion plan with zero-discount warrants and an up-to-¥300 million bond

    The structure: Modalis says the package can raise ¥1.33 billion, but only up to ¥300 million arrives upfront via a 0% private bond. The rest depends on EVO FUND exercising 24 million shares' worth of warrants at prices that reset to the previous day's close, with a ¥28 floor and disclosed maximum dilution of 24.91%.

Japan Pharma & Healthcare Company News (Page 5) | Tokyo Brief